Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Jacob Challand Kofoed, PhD
Scientific Director, Peptide Research 1  at Novo Nordisk A/S
Speaker

Profile

Jacob Challand Kofoed is a Scientific Director, Peptide Research 1 at Novo Nordisk, specializing in peptide research, automation, and digital innovation. With over 19 years of experience in pharmaceutical research, he has led the development of high-throughput platforms for peptide synthesis and purification and plays a key role in advancing drug candidate projects. Jacob holds a PhD in Bioorganic Chemistry from University of Berne (Switzerland). He is an inventor on more than 20 patent applications covering peptide therapeutics and enabling technologies

Agenda Sessions

  • Next Generation GLP-1 Therapeutics

    13:50